Infantile‐Onset Ascending Hereditary Spastic Paraplegia due to a Homozygous ALS2 Exons 24–25 Deletion: Expanding the Genotypic Spectrum
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmga.70010 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Vito Luigi Colona und 15 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Neurorehabilitation, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Exons, Sequence Deletion, Guanine Nucleotide Exchange Factors. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Ministry of Health with "Current Research funds", Ministero della Salute.
Abstract (Originalsprache)
We describe a novel homozygous intragenic deletion in the ALS2 gene in an 8‐year‐old boy with Infantile‐onset Ascending Hereditary Spastic Paraplegia (IAHSP) and oculomotor apraxia, thereby contributing to the expanding genetic landscape of ALS2 ‐related disorders. Comprehensive neurological evaluation, chromosomal microarray analysis (CMA), and trio‐based whole exome sequencing (WES) were performed. CMA revealed a run of homozygosity (ROH) at 2q33.1. WES identified a homozygous deletion encompassing exons 24–25 of ALS2 , inherited from heterozygous parents. This clinical phenotype was consistent with the IAHSP spectrum , and no previous cases due to intragenic deletion have been reported. Our findings further expand the mutational spectrum of ALS2 ‐related disorders and underscore the relevance of combining CMA and WES in the diagnostic workup of early‐onset motor disorders, particularly in consanguineous families and unresolved cases. Greater awareness of rare intragenic deletions may improve early recognition and facilitate accurate genetic counseling in pediatric neurogenetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Neurorehabilitation, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Rare Diseases and Medical Genetics Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Unit of Muscular and Neurodegenerative Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Medical and Laboratory Genetics Unit, AORN, Antonio Cardarelli, Naples, Italy.
ORCID-Profile: Vito Luigi Colona, Silvia Genovese, Enrico Bertini, Antonio Novelli
Förderung
- Italian Ministry of Health with "Current Research funds"
- Ministero della Salute
Zitieren
APA
Colona, V. L., Gnazzo, M., Genovese, S., Vasco, G., Travaglini, L., Sabbadini, M., Macchiaiolo, M., Nicita, F., Sartorelli, J., Piscopo, C., Castelli, E., Bertini, E., Bartuli, A., Novelli, A., Bella, G. D., & Vecchio, D. (2025). Infantile‐Onset Ascending Hereditary Spastic Paraplegia due to a Homozygous ALS2 Exons 24–25 Deletion: Expanding the Genotypic Spectrum. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmga.70010
Vancouver
Colona VL, Gnazzo M, Genovese S, Vasco G, Travaglini L, Sabbadini M, et al. Infantile‐Onset Ascending Hereditary Spastic Paraplegia due to a Homozygous ALS2 Exons 24–25 Deletion: Expanding the Genotypic Spectrum. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmga.70010
BibTeX
@article{Colona2025,
author = {Colona, Vito Luigi and Gnazzo, Maria and Genovese, Silvia and Vasco, Gessica and Travaglini, Lorena and Sabbadini, Maurizio and Macchiaiolo, Marina and Nicita, Francesco and Sartorelli, Jacopo and Piscopo, Carmelo and Castelli, Enrico and Bertini, Enrico and Bartuli, Andrea and Novelli, Antonio and Bella, Gessica Della and Vecchio, Davide},
title = {Infantile‐Onset Ascending Hereditary Spastic Paraplegia due to a Homozygous ALS2 Exons 24–25 Deletion: Expanding the Genotypic Spectrum},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmga.70010}
}
EUVIMED